Hand eczema

New England Journal of Medicine

Volumn 367, Issue 19, 2012, Pages 1829-1837

  Coenraads, Pieter Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; BETAMETHASONE; EMOLLIENT AGENT; ETRETIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MOMETASONE FUROATE; PIMECROLIMUS; PLACEBO; PSORALEN; RETINOID DERIVATIVE; TACROLIMUS;

ARTICLE; DRUG EFFICACY; DRY SKIN; HAND ECZEMA; HUMAN; LIPID BLOOD LEVEL; MEDICAL HISTORY; NAUSEA; PATIENT CARE; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIDE EFFECT; SKIN EDEMA; SKIN EXAMINATION; SKIN PAIN; SKIN PROTECTION; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84868546303     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1104084     Document Type: Article

References (49)

1. Veien NK, Hattel T, Laurberg G. Hand eczema: causes, course, and prognosis II. Contact Dermatitis 2008;58:335-9.
2. Thyssen JP, Johansen JD, Linneberg A, Menne T. The epidemiology of hand eczema in the general population - prevalence and main findings. Contact Dermatitis 2010;62:75-87.
3. Diepgen TL. Occupational skin-disease data in Europe. Int Arch Occup Environ Health 2003;76:331-8.
4. Holness DL, Nethercott JR. Work outcome in workers with occupational skin disease. Am J Ind Med 1995;27:807-15.
5. Moberg C, Alderling M, Meding B. Hand eczema and quality of life: a population-based study. Br J Dermatol 2009;161:397-403.
6. Diepgen TL, Andersen KE, Brandao FM, et al. Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol 2009;160:353-8.
7. Lynde C, Guenther L, Diepgen TL, et al. Canadian hand dermatitis management guidelines. J Cutan Med Surg 2010;14:267-84. [Erratum, J Cutan Med Surg 2011;15:360.]
8. Menné T, Johansen JD, Sommerlund M, Veien NK. Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema. Contact Dermatitis 2011;65:3-12.
9. Jensen CS, Menné T, Johansen JD. Systemic contact dermatitis after oral exposure to nickel: a review with a modified meta-analysis. Contact Dermatitis 2006;54:79-86.
10. Belsito DV. Patch testing with a standard allergen ("screening" ) tray: rewards and risks. Dermatol Ther 2004;17:231-9.
11. Hersle K, Mobacken H. Hyperkeratotic dermatitis of the palms. Br J Dermatol 1982;107:195-201.
12. Nilsson E, Mikaelsson B, Andersson S. Atopy, occupation and domestic work as risk factors for hand eczema in hospital workers. Contact Dermatitis 1985;13:216-23.
13. Johansen JD, Hald M, Andersen BL, et al. Classification of hand eczema: clinical and aetiological types: based on the guideline of the Danish Contact Dermatitis Group. Contact Dermatitis 2011;65:13-21.
14. Molin S, Diepgen TL, Ruzicka T, Prinz JC. Diagnosing chronic hand eczema by an algorithm: a tool for classification in clinical practice. Clin Exp Dermatol 2011;36:595-601.
15. Weistenhöfer W, Baumeister T, Drexler H, Kütting B. An overview of skin scores used for quantifying hand eczema: a critical update according to the criteria of evidence-based medicine. Br J Dermatol 2010;162:239-50.
16. Alikhan A, Cheng LS, Ale I, et al. Revised minimal baseline series of the International Contact Dermatitis Research Group: evidence-based approach. Dermatitis 2011;22:121-2.
17. Saripalli YV, Achen F, Belsito DV. The detection of clinically relevant contact allergens using a standard screening tray of twenty-three allergens. J Am Acad Dermatol 2003;49:65-9.
18. Flohr C, Johansson SG, Wahlgren CF, Williams H. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004;114:150-8.
19. Hald M, Agner T, Blands J, et al. Clinical severity and prognosis of hand eczema. Br J Dermatol 2009;160:1229-36.
20. Diepgen TL, Elsner P, Schliemann S, et al. Guideline on the management of hand eczema ICD-10 code: L20, L23, L24, L25, L30. J Dtsch Dermatol Ges 2009;7: Suppl 3:S1-S16.
21. Van Coevorden AM, Coenraads PJ, Svensson A, et al. Overview of studies of treatments for hand eczema - the EDEN hand eczema survey. Br J Dermatol 2004;151:446-51.
22. English J, Aldridge R, Gawkrodger DJ, et al. Consensus statement on the management of chronic hand eczema. Clin Exp Dermatol 2009;34:761-9.
23. Kucharekova M, Van De Kerkhof PC, Van Der Valk PG. A randomized comparison of an emollient containing skin-related lipids with a petrolatum-based emollient as adjunct in the treatment of chronic hand dermatitis. Contact Dermatitis 2003;48:293-9.
24. Lodén M, Wirén K, Smerud KT, et al. The effect of a corticosteroid cream and a barrier-strengthening moisturizer in hand eczema: a double-blind, randomized, prospective, parallel group clinical trial. J Eur Acad Dermatol Venereol 2012;26:597-601.
25. Bauer A, Schmitt J, Bennett C, et al. Interventions for preventing occupational irritant hand dermatitis. Cochrane Database Syst Rev 2010;6:CD004414.
26. Ibler KS, Agner T, Hansen JL, Gluud C. The Hand Eczema Trial (HET): design of a randomised clinical trial of the effect of classification and individual counselling versus no intervention among healthcare workers with hand eczema. BMC Dermatol Pub Med 2010;10:8-18.
27. Work healthy: asthma, eczema and your career. Stockholm: Karolinska Institutet School of Public Health, 2010 (http://www.jobbafrisk.se/english).
28. Kwon S, Campbell LS, Zirwas MJ. Role of protective gloves in the causation and treatment of occupational irritant contact dermatitis. J Am Acad Dermatol 2006;55:891-6.
29. Ramsing DW, Agner T. Effect of glove occlusion on human skin (II): long-term experimental exposure. Contact Dermatitis 1996;34:258-62.
30. Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 1999;140:882-6.
31. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol 1996;35:615-9.
32. Belsito DV, Fowler JF Jr, Marks JG Jr, et al. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 2004;73:31-8.
33. Hordinsky M, Fleischer A, Rivers JK, Poulin Y, Belsito D, Hultsch T. Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trial. Dermatology 2010;221:71-7.
34. Schnopp C, Remling R, Möhrenschlager M, Weigl L, Ring J, Abeck D. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol 2002;46:73-7.
35. Krejci-Manwaring J, McCarty MA, Camacho F, et al. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. J Drugs Dermatol 2008;7:643-6.
36. Rosén K, Mobacken H, Swanbeck G. Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta Derm Venereol 1987;67:48-54.
37. Sezer E, Etikan I. Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema. Photo-dermatol Photoimmunol Photomed 2007;23:10-4.
38. Halpern SM, Anstey AV, Dawe RS, et al. Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group. Br J Dermatol 2000;142:22-31.
39. van Coevorden AM, Kamphof WG, van Sonderen E, Bruynzeel DP, Coenraads PJ. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. Arch Dermatol 2004;140:1463-6.
40. Tzaneva S, Kittler H, Thallinger C, Honigsmann H, Tanew A. Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema. Photodermatol Photoimmunol Photomed 2009;25:101-5.
41. Ruzicka T, Lynde CW, Jemec GB, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008;158:808-17.
42. Bissonnette R, Worm M, Gerlach B, et al. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol 2010;162:420-6.
43. Thestrup-Pedersen K, Andersen KE, Menné T, Veien NK. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin: a singleblind placebo-controlled study. Acta Derm Venereol 2001;81:353-5.
44. Hughes R, Collins P, Rogers S. Further experience of using azathioprine in the treatment of severe atopic dermatitis. Clin Exp Dermatol 2008;33:710-1.
45. Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2007;21:606-19.
46. Murray ML, Cohen JB. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol 2007;32:23-7.
47. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 1996;76:371-6.
48. Egan CA, Rallis TM, Meadows KP, Krueger GG. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 1999;40:612-4.
49. Kaae J, Menné T, Carlsen BC, Zachariae C, Thyssen JP. The hands in health and disease of individuals with filaggrin loss-of-function mutations: clinical reflections on the hand eczema phenotype. Contact Dermatitis 2012;67:119-24.